Last updated: August 22, 2026
A blood glucose test measures the concentration of glucose in the blood and is one of the most commonly performed laboratory tests worldwide. It is used to help screen for and diagnose diabetes and prediabetes, investigate suspected hypoglycemia or hyperglycemia, and monitor glucose-related disorders.
Correct interpretation requires more than looking at a single number. The type of sample, fasting status, timing of collection, specimen handling, analytical method, medications, acute illness, and clinical context can all influence the result.
What Is Blood Glucose?
Glucose is an important carbohydrate and a major source of energy for many tissues in the body. Blood glucose concentrations are controlled primarily through the coordinated effects of insulin, glucagon, hepatic glucose production, glucose uptake, dietary intake, and hormonal responses.
After eating, carbohydrates are broken down into glucose and other molecules. Glucose enters the bloodstream, stimulating pancreatic beta cells to release insulin. Insulin promotes glucose uptake and storage and helps reduce circulating glucose concentrations.
During fasting, glucagon and other counter-regulatory hormones help maintain glucose by stimulating hepatic glycogenolysis and gluconeogenesis.
Why Is a Blood Glucose Test Ordered?
A glucose test may be requested for several reasons, including:
- Screening for type 2 diabetes.
- Screening for prediabetes.
- Investigation of symptoms of hyperglycemia.
- Investigation of suspected hypoglycemia.
- Monitoring individuals with known diabetes.
- Assessment during acute illness.
- Part of a routine metabolic or chemistry panel.
- Evaluation during pregnancy using specific gestational diabetes protocols.
Types of Blood Glucose Tests
1. Fasting Plasma Glucose — FPG
Fasting plasma glucose is measured after at least 8 hours without caloric intake. Water is generally permitted.
When plasma glucose is being used diagnostically, venous plasma measured by an appropriate laboratory method is preferred.
2. Random Plasma Glucose — RPG
A random glucose sample may be collected at any time of day regardless of the most recent meal.
Random plasma glucose is particularly important when a patient has classic symptoms of hyperglycemia such as polyuria, polydipsia, unexplained weight loss, or a hyperglycemic crisis.
3. Oral Glucose Tolerance Test — OGTT
The standard diagnostic OGTT measures plasma glucose before and 2 hours after ingestion of a glucose load containing the equivalent of 75 g of anhydrous glucose.
4. HbA1c
HbA1c is not a direct measurement of the glucose concentration at the time of blood collection. It reflects average glycemic exposure over approximately the previous 2–3 months, with greater influence from more recent glucose exposure.
For a detailed laboratory-focused discussion of methodology and its role in diabetes diagnosis and monitoring, read our complete HbA1c laboratory guide.
Blood Glucose Normal Range
Important: Diagnostic thresholds should not be confused with a laboratory's local reference interval. Laboratories should report ranges and interpretation appropriate to their validated method and clinical setting.
| Test | Typical non-diabetic category |
|---|---|
| Fasting plasma glucose | <100 mg/dL (<5.6 mmol/L) |
| 2-hour glucose after 75-g OGTT | <140 mg/dL (<7.8 mmol/L) |
| HbA1c | <5.7% |
These values apply to nonpregnant individuals for diabetes classification and should not automatically be applied to pregnancy, children with specific disorders, critically ill patients, or other special clinical situations.
2026 Diabetes Diagnostic Criteria
According to the American Diabetes Association Standards of Care in Diabetes—2026, diabetes in nonpregnant individuals can be diagnosed using one of the following criteria:
| Test | Diabetes threshold |
|---|---|
| HbA1c | ≥6.5% (≥48 mmol/mol) |
| Fasting plasma glucose | ≥126 mg/dL (≥7.0 mmol/L) |
| 2-hour plasma glucose during 75-g OGTT | ≥200 mg/dL (≥11.1 mmol/L) |
| Random plasma glucose | ≥200 mg/dL (≥11.1 mmol/L) with classic hyperglycemic symptoms or hyperglycemic crisis |
Diagnostic caution: In the absence of unequivocal hyperglycemia, diagnosis generally requires confirmation with a second abnormal result, either from the same test on another occasion or another accepted diagnostic test.
Prediabetes Ranges
| Test | Prediabetes range |
|---|---|
| HbA1c | 5.7–6.4% |
| Fasting plasma glucose | 100–125 mg/dL (5.6–6.9 mmol/L) |
| 2-hour OGTT | 140–199 mg/dL (7.8–11.0 mmol/L) |
Prediabetes represents an intermediate category of glucose regulation rather than a diagnosis based on symptoms alone.
Glucose abnormalities are frequently evaluated alongside other cardiometabolic risk markers. See our guide to LDL, HDL, triglycerides, and lipid profile interpretation.
High Blood Glucose: Hyperglycemia
Hyperglycemia refers to an abnormally elevated blood glucose concentration. Its significance depends on the degree of elevation, fasting status, clinical presentation, medications, and whether the elevation is persistent.
Common causes of elevated glucose include:
- Diabetes mellitus.
- Prediabetes.
- Acute physiological stress.
- Severe infection or systemic illness.
- Corticosteroid therapy.
- Cushing syndrome.
- Pancreatic disorders.
- Endocrine disorders involving excess counter-regulatory hormones.
- Parenteral or enteral glucose administration.
Symptoms that may accompany significant hyperglycemia
- Frequent urination.
- Excessive thirst.
- Blurred vision.
- Fatigue.
- Unexplained weight loss.
Severe hyperglycemia may occur with diabetic ketoacidosis or hyperosmolar hyperglycemic state and requires urgent medical assessment.
Urine testing can provide additional laboratory information in patients with suspected metabolic abnormalities. Review our complete urinalysis laboratory guide.
Low Blood Glucose: Hypoglycemia
Hypoglycemia generally refers to an abnormally low glucose concentration. In people with diabetes, a glucose value below 70 mg/dL is widely used as an alert threshold for low blood glucose.
Possible causes include:
- Excess insulin.
- Sulfonylurea or other glucose-lowering medications.
- Prolonged fasting.
- Alcohol use.
- Severe liver disease.
- Critical illness.
- Adrenal insufficiency.
- Insulinoma and other rare endocrine disorders.
- Preanalytical loss of glucose due to delayed specimen processing.
Clinical safety: Marked hypoglycemia can cause confusion, seizures, loss of consciousness, and other serious complications. Symptomatic or severe low glucose requires prompt clinical assessment and treatment.
The liver has a central role in glucose homeostasis through glycogen storage, glycogenolysis, and gluconeogenesis. For related laboratory testing, see our complete liver function tests guide.
Fasting vs Random Blood Glucose
| Feature | Fasting Glucose | Random Glucose |
|---|---|---|
| Fasting required | Yes, at least 8 hours | No |
| Main use | Screening and diagnosis | Evaluation of symptomatic hyperglycemia |
| Meal influence | Reduced | Significant |
| Diagnostic threshold | ≥126 mg/dL | ≥200 mg/dL with classic symptoms or hyperglycemic crisis |
Oral Glucose Tolerance Test
The OGTT evaluates how efficiently the body handles a standardized oral glucose load.
For a standard 75-g OGTT in nonpregnant adults:
- The patient fasts for at least 8 hours.
- A fasting blood sample is collected.
- The patient consumes the standardized glucose solution.
- A 2-hour plasma glucose sample is collected according to the protocol.
A 2-hour plasma glucose concentration of 200 mg/dL (11.1 mmol/L) or greater meets a diagnostic criterion for diabetes in a nonpregnant individual.
Pregnancy uses different screening and diagnostic protocols and should be interpreted using pregnancy-specific criteria.
Blood Glucose vs HbA1c
| Feature | Plasma Glucose | HbA1c |
|---|---|---|
| Measures | Glucose at the time of collection | Longer-term glycemic exposure |
| Fasting | Required for FPG | Not required |
| Acute changes | Highly responsive | Less affected by short-term changes |
| Important limitations | Preanalytical glycolysis and biological variation | Hemoglobin variants, altered red-cell turnover and other conditions |
HbA1c should be measured with an appropriately standardized method when used for diagnosis. Conditions that alter red blood cell survival or the relationship between HbA1c and glycemia may make plasma glucose criteria more appropriate.
For normal ranges, high HbA1c, prediabetes, and diabetes interpretation, see our HbA1c blood test guide.
Blood Glucose Sample Requirements
Preferred diagnostic sample
Venous plasma is recommended when glucose is used to diagnose diabetes.
Common specimen types
- Venous plasma.
- Serum.
- Whole blood in selected applications.
- Capillary blood for glucose meters and point-of-care monitoring.
Values obtained from different specimen types and measurement systems should not automatically be assumed to be interchangeable.
Glycolysis and Preanalytical Errors
Preanalytical handling is one of the most important aspects of accurate glucose testing.
After blood collection, blood cells continue consuming glucose through glycolysis. If cells remain in contact with plasma or serum, the measured glucose concentration can progressively decrease.
Laboratory guidance reports that glucose in unprocessed whole blood may decrease by approximately 5–7% per hour, although the rate varies with temperature, glucose concentration, leukocyte count, and other factors.
Why delayed processing matters
A falsely decreased glucose concentration can potentially result in:
- Failure to detect diabetes near a diagnostic threshold.
- Misclassification of prediabetes.
- Apparent hypoglycemia.
- Incorrect clinical interpretation.
Sodium fluoride is not an immediate solution
A common misconception is that sodium fluoride immediately stops glycolysis. Fluoride inhibits enolase, but glycolysis can continue during the early period after collection.
Current laboratory recommendations emphasize either rapid separation of plasma from blood cells or the use of tubes containing a rapidly acting glycolysis inhibitor such as a citrate-buffer system, according to laboratory protocol.
Marked leukocytosis can accelerate cellular glucose consumption in an unseparated specimen. For further interpretation, see our guide to high WBC count and leukocytosis.
Laboratory pearl: For glucose samples collected near diagnostic decision limits, specimen handling can be as important as analytical precision.
Laboratory Methods for Glucose Measurement
Modern chemistry analyzers commonly measure glucose using enzymatic techniques.
Hexokinase method
The hexokinase method is widely used in clinical laboratories and is generally considered a highly specific reference-type enzymatic approach for routine laboratory measurement.
Glucose oxidase method
Glucose oxidase-based techniques are also widely used, particularly in some analyzers and point-of-care systems.
Laboratory professionals should interpret results according to the specific analytical platform, reagent system, calibration traceability, measuring interval, interference characteristics, and validated laboratory procedure.
Factors That Can Affect Blood Glucose Results
Preanalytical factors
- Failure to fast when fasting glucose is required.
- Delayed centrifugation.
- Improper specimen storage.
- Prolonged cellular contact.
- Marked leukocytosis.
- Incorrect tube or collection procedure.
Physiological and clinical factors
- Recent food intake.
- Stress.
- Exercise.
- Acute illness.
- Pregnancy.
- Hormonal disorders.
- Medications.
When hepatic disease is suspected, glucose results may be interpreted alongside other biochemical findings. Learn more about high ALT and AST levels and their laboratory interpretation.
Renal function can also be important in the broader metabolic assessment. See our guide to creatinine, eGFR, and kidney function interpretation.
Analytical factors
- Calibration problems.
- Reagent deterioration.
- Instrument malfunction.
- Interference specific to the analytical method.
- Quality-control failure.
Quality Control in Glucose Testing
Internal quality control is essential to ensure that glucose results remain analytically reliable before patient results are released.
Laboratories should follow their validated quality-control plan and manufacturer instructions and assess:
- Control results at appropriate concentration levels.
- Levey–Jennings charts.
- Systematic shifts or trends.
- Applicable Westgard or laboratory-specific QC rules.
- Calibration status.
- Reagent and calibrator lot changes.
- Proficiency testing or external quality assessment performance.
For a deeper discussion of laboratory QC, review our internal quality control, Westgard rules, and Levey–Jennings guide.
Beyond individual QC results, laboratories should monitor broader measures of analytical and operational performance. See our guide to laboratory quality indicators, KPIs, and ISO 15189 quality management.
QC principle: Patient glucose results should not be released when required quality-control criteria indicate that the analytical system is unacceptable. The cause should be investigated and documented according to the laboratory's quality management procedure.
Critical Glucose Results
There is no single universal critical glucose value that applies to every laboratory.
Critical or panic limits should be established by the laboratory in collaboration with its clinical leadership and according to institutional policy, patient population, regulatory requirements, and accreditation standards.
A glucose concentration designated as critical should be managed using the laboratory's approved critical-result notification procedure.
This is especially important because dangerously low or markedly elevated glucose concentrations may require immediate clinical intervention.
Laboratory Interpretation Approach
A systematic laboratory approach may include the following:
- Confirm specimen identification.
- Determine whether the patient was fasting.
- Review specimen type and processing time.
- Check internal QC and analyzer status.
- Assess the magnitude of the result.
- Compare with previous results when available.
- Consider possible preanalytical or analytical interference.
- Apply diagnostic thresholds only in the appropriate clinical context.
- Follow laboratory policy for critical results.
Laboratory interpretation often requires correlation with hematological findings and the patient's broader clinical picture. See our complete blood count (CBC) interpretation guide.
Abnormal renal function may also be relevant to the broader clinical interpretation of metabolic results. Review our detailed guide to high creatinine levels and eGFR.
Example 1
A fasting venous plasma glucose of 132 mg/dL exceeds the diabetes diagnostic threshold. However, in an asymptomatic patient without unequivocal hyperglycemia, a single abnormal result should generally be confirmed according to accepted diagnostic guidance.
Example 2
A random plasma glucose of 205 mg/dL should not automatically be interpreted identically in every patient. Its diagnostic significance depends strongly on whether classic symptoms of hyperglycemia or a hyperglycemic crisis are present.
Example 3
An unexpectedly low glucose result from a sample that remained unseparated for an extended period should prompt consideration of ongoing cellular glycolysis before the result is interpreted clinically.
Frequently Asked Questions
What is a normal fasting blood sugar?
For classification of nonpregnant individuals, fasting plasma glucose below 100 mg/dL (5.6 mmol/L) is generally considered below the prediabetes threshold.
Is 100 mg/dL fasting glucose normal?
A fasting plasma glucose of 100 mg/dL is at the lower boundary of the ADA prediabetes category of 100–125 mg/dL. Interpretation should consider repeat testing, overall risk, and other clinical information.
What fasting glucose level indicates diabetes?
A fasting plasma glucose of 126 mg/dL (7.0 mmol/L) or higher meets a diagnostic criterion for diabetes in nonpregnant individuals. In the absence of unequivocal hyperglycemia, confirmation is generally required.
What random blood sugar level indicates diabetes?
A random plasma glucose of 200 mg/dL (11.1 mmol/L) or greater can establish a diagnosis when accompanied by classic symptoms of hyperglycemia or a hyperglycemic crisis.
What blood sugar level is considered low?
In people with diabetes, a glucose concentration below 70 mg/dL is commonly considered hypoglycemia and warrants prompt attention.
Can a glucose test diagnose diabetes by itself?
It can contribute directly to diagnosis, but interpretation depends on the type of test and clinical situation. In an asymptomatic individual without unequivocal hyperglycemia, confirmation of an abnormal result is usually required.
Can delayed blood sample processing lower glucose?
Yes. Blood cells continue to consume glucose after collection, so delayed separation can cause a falsely decreased laboratory result.
Is the gray-top fluoride tube enough to stop glycolysis immediately?
Not necessarily. Fluoride slows glycolysis but does not completely prevent the initial decline in glucose concentration. Laboratories should follow validated specimen-handling procedures.
Is HbA1c better than fasting glucose?
Neither test is universally superior. They measure different aspects of glycemia and each has advantages and limitations.
Does pregnancy use the same glucose ranges?
No. Gestational diabetes screening and diagnosis use pregnancy-specific testing protocols and thresholds.
Authoritative References
- American Diabetes Association Professional Practice Committee for Diabetes. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026 . Diabetes Care. 2026;49(Suppl 1):S27–S49.
- Sacks DB, et al. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus . Clinical Chemistry.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Diabetes Tests & Diagnosis .
- Centers for Disease Control and Prevention (CDC): Low Blood Sugar .
- World Health Organization. Guidance related to diabetes diagnosis and glucose measurement.